Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Change in Account Payables (2016 - 2025)

Avanos Medical (AVNS) has disclosed Change in Account Payables for 13 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 266.67% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $600000.0 through Dec 2025, up 166.67% year-over-year, with the annual reading at $600000.0 for FY2025, 166.67% up from the prior year.
  • Change in Account Payables hit $1.1 million in Q4 2025 for Avanos Medical, roughly flat from $1.1 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $30.2 million in Q1 2022 to a low of -$14.2 million in Q3 2023.
  • Historically, Change in Account Payables has averaged $463157.9 across 5 years, with a median of $1.1 million in 2025.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 587.1% in 2022 and later tumbled 2466.67% in 2023.
  • Year by year, Change in Account Payables stood at -$9.7 million in 2021, then skyrocketed by 113.4% to $1.3 million in 2022, then increased by 23.08% to $1.6 million in 2023, then plummeted by 81.25% to $300000.0 in 2024, then surged by 266.67% to $1.1 million in 2025.
  • Business Quant data shows Change in Account Payables for AVNS at $1.1 million in Q4 2025, $1.1 million in Q3 2025, and $4.8 million in Q2 2025.